Yes. John Rose disclosed 1 sale of Core Laboratories (CLB) stock on Nov 12, 2019, in STOCK Act reports. Added together, the disclosed ranges come to $1K-$15K.
Yes. John Rose disclosed 1 sale of Core Laboratories (CLB) stock on Nov 12, 2019, in STOCK Act reports. Added together, the disclosed ranges come to $1K-$15K.
How big were John Rose's Core Laboratories trades?
STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed ranges come to $1K-$15K.
Did John Rose make these Core Laboratories trades personally?
Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.
Does John Rose still own Core Laboratories stock?
This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.
When did John Rose report these trades?
The latest filing is dated Dec 11, 2019. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.
Where does this data come from?
From periodic transaction reports filed under the STOCK Act with the Clerk of the House. Every trade links to the original filing.
Loading